Clinical Trial

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy

Unknown Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Current guidelines mandate Helicobacter pylori (H. Pylori) eradication with 2-3 antibiotics for 14 days ,This may result in multiple side effects and in eradication of important bacterial species to human health, exposing humans to multiple disease conditions. Preservation of fecal microbiome prior to antibiotic therapy and auto-transplantation of the microbes post H. pylori eradication, will enable avoiding eradication of beneficial microbial populations and perhaps protect from consequent disease conditions.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05329636
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: Weizmann Institute of Science
Conditions Helicobacter Pylori Infection
Enrollment 30 participants
Start Date 2018-09-26
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-08